GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Livongo Health Inc (NAS:LVGO) » Definitions » Intrinsic Value: Projected FCF

Livongo Health (Livongo Health) Intrinsic Value: Projected FCF : $0.00 (As of May. 05, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Livongo Health Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-05-05), Livongo Health's Intrinsic Value: Projected FCF is $0.00. The stock price of Livongo Health is $132.68. Therefore, Livongo Health's Price-to-Intrinsic-Value-Projected-FCF of today is 0.0.

The historical rank and industry rank for Livongo Health's Intrinsic Value: Projected FCF or its related term are showing as below:

LVGO's Price-to-Projected-FCF is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.7
* Ranked among companies with meaningful Price-to-Projected-FCF only.

Livongo Health Intrinsic Value: Projected FCF Historical Data

The historical data trend for Livongo Health's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Livongo Health Intrinsic Value: Projected FCF Chart

Livongo Health Annual Data
Trend Dec17 Dec18 Dec19
Intrinsic Value: Projected FCF
- - -

Livongo Health Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Livongo Health's Intrinsic Value: Projected FCF

For the Medical Devices subindustry, Livongo Health's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Livongo Health's Price-to-Projected-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Livongo Health's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Livongo Health's Price-to-Projected-FCF falls into.



Livongo Health Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)



Livongo Health  (NAS:LVGO) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Livongo Health's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=132.68/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Livongo Health Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Livongo Health's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Livongo Health (Livongo Health) Business Description

Traded in Other Exchanges
N/A
Address
150 West Evelyn Avenue, Suite 150, Mountain View, CA, USA, 94041
Livongo Health Inc provides a data science and technology enabled platform for detection of diabetes. Its additional solutions include Livongo for Hypertension, Livongo for Prediabetes and Weight Management, and Livongo for Behavioral Health by myStrength. The company's client comprise of employers, health plans, government entities, and labor unions. Its operations are primarily located in the United States.
Executives
Lee Shapiro officer: Chief Financial Officer C/O ALLSCRIPTS HEALTCHARE SOLUTIONS, 2401 COMMERCE DR, LIBERTYVILLE IL 60048
Glen Tullman director, officer: Executive Chairman C/O LIVONGO HEALTH, INC., 150 WEST EVELYN AVENUE, SUITE 150, MOUNTAIN VIEW CA 94041
Karen L Daniel director 2801 80TH STREET, KENOSHA WI 53141
Philip E Green director C/O LIVONGO HEALTH, INC, 150 WEST EVELYN AVENUE, SUITE 150, MOUNTAIN VIEW CA 94041
Kenneth I Chenault 10 percent owner C/O GENERAL CATALYST, 20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138
Gc Venture Lh Manager, Llc 10 percent owner 20 UNIVERSITY ROAD, 4TH FLOOR CAMBRIDGE MA 02138
Gc Partners Holdings, Lp 10 percent owner 20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138
Gcgm Investment Holdings, Lp 10 percent owner 20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138
General Catalyst Group Management Holdings Gp, Llc 10 percent owner 20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138
General Catalyst Group Management Holdings, L.p. 10 percent owner 20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138
General Catalyst Gp Vi, Llc 10 percent owner 20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138
General Catalyst Gp Viii, Llc 10 percent owner 20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138
General Catalyst Partners Vi, L.p. 10 percent owner 20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138
General Catalyst Group Viii Supplemental, L.p. 10 percent owner 20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138
General Catalyst Group Viii, L.p. 10 percent owner 20 UNIVERSITY ROAD, 4TH FLOOR, CAMBRIDGE MA 02138

Livongo Health (Livongo Health) Headlines

From GuruFocus

Livongo Health: Telehealth Is the Next Big Thing

By Ishan Majumdar Ishan Majumdar 07-14-2020